Prices of newer HIV drugs too high, according to MSF
Poor people living with the virus struggle to get their hands on newer HIV drugs.
JOHANNESBURG - Doctors Without Borders / Médecins Sans Frontières (MSF) has released a report showing that prices of newer HIV drugs are too high, making it difficult for poor people living with the virus to afford them.
The international medical humanitarian organisation released the report at the International Aids Conference in Durban today.
MSF says while the prices of older HIV drugs continue to decline, the world - especially third world countries - risk facing an HIV treatment crisis if newer drugs are not made affordable.
#AidsConference2016 Doctors Without Borders(MSF) says prices of older HIV drugs continue to decline, while newer ones remain highly priced.— EWN Reporter (@ewnreporter) July 21, 2016
The organisation's Dr Vivian Cox says the price of older drugs has decreased by 26 percent since 2014 but newer drugs are costing 18 times more making it impossible for the poor to have other options.
The organisation says the reason pricing for new drugs is so high is because pharmaceutical corporations maintain monopolies that block cheaper generic competition.